TP53 and hereditary cancer: For young women with EC considering delay of hysterectomy for fertility reasons (e.g., progesterone therapy), molecular classification of her diagnostic endometrial specimen could help guide management as either MMR-D (depending on germline results post hereditary cancer referral) or p53 abn categorization would discourage a conservative approach.